CN111588941A - Infusion port and method of use - Google Patents
- ️Fri Aug 28 2020
CN111588941A - Infusion port and method of use - Google Patents
Infusion port and method of use Download PDFInfo
-
Publication number
- CN111588941A CN111588941A CN202010466767.9A CN202010466767A CN111588941A CN 111588941 A CN111588941 A CN 111588941A CN 202010466767 A CN202010466767 A CN 202010466767A CN 111588941 A CN111588941 A CN 111588941A Authority
- CN
- China Prior art keywords
- port
- liquid storage
- storage cavity
- wall
- bottom inner Prior art date
- 2020-05-28 Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 46
- 238000003860 storage Methods 0.000 claims abstract description 45
- 238000002347 injection Methods 0.000 claims abstract description 27
- 239000007924 injection Substances 0.000 claims abstract description 27
- 239000013543 active substance Substances 0.000 claims abstract description 23
- 239000012530 fluid Substances 0.000 claims description 9
- 230000006378 damage Effects 0.000 claims description 5
- 208000027418 Wounds and injury Diseases 0.000 claims description 4
- 208000014674 injury Diseases 0.000 claims description 4
- 230000000149 penetrating effect Effects 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 239000000741 silica gel Substances 0.000 abstract description 3
- 229910002027 silica gel Inorganic materials 0.000 abstract description 3
- 230000000472 traumatic effect Effects 0.000 abstract description 2
- 206010033675 panniculitis Diseases 0.000 description 7
- 210000004304 subcutaneous tissue Anatomy 0.000 description 7
- 238000004891 communication Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
- A61M2005/1581—Right-angle needle-type devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
- A61M2005/1586—Holding accessories for holding infusion needles on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
- A61M2005/1587—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body suitable for being connected to an infusion line after insertion into a patient
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The invention discloses an infusion port, which comprises a port body, a liquid storage cavity arranged in the port body, a connecting pipe used for fixing a catheter and the port body, and an injection piece fixedly arranged on the port body, wherein the plane of the lowest edge of the liquid storage cavity is always higher than or equal to the lowest point of the catheter, and the liquid storage cavity and the catheter have a height difference h, wherein h is more than or equal to 0. The invention has the following beneficial effects: because the height difference exists between the bottom inner wall of the port body and the lowest point of the conduit, the direct flow is ensured in the infusion process, and the medical active substance can not remain in the liquid storage cavity; and the liquid storage cavity and the silica gel are obliquely arranged and matched with the linear type non-traumatic needle, so that the operation and the use of medical personnel are facilitated.
Description
Technical Field
The invention relates to the technical field of medical articles, in particular to an infusion port and a using method thereof.
Background
The port is generally used for medical infusion and is used in cooperation with a non-invasive needle, and medical liquid is infused into the body of a patient through the non-invasive needle and the port to treat diseases of the patient. The structure of the transfusion port is more general, which is disclosed in US patent No. US4723948, US patent No. US4861341, US patent No. US5281205, US patent No. US9017300, Chinese patent No. CN105163795B, the general structure of which is shown in figure 1, comprising a
transfusion port body101; a
reservoir102 for containing a medically active substance; a connecting
tube103 for connecting the conduits to establish a flow connection between the reservoir and the
conduit104. The
port body101 is provided with an
injection piece105 at the top for piercing with an
atraumatic needle106 and entering into the
reservoir102. The
atraumatic needle106 is typically a 90 ° right angle infusion needle.
Such a port can be implanted in a patient as is known from European patent EP1675641B1 by introducing the port, for example, under the skin (subcutaneous tissue) of the patient and fixing it there. The port is then used for introducing drugs, blood products, nutrients or other medically active substances into the venous or arterial system of a patient, by means of which the active substances can be administered to the patient in particular repeatedly over a longer period of time. Since the port can be completely implanted under the skin of the patient, the risk of infection is reduced, and the active substance can be specifically administered over a longer period of time for treating the patient, without the patient having to be hospitalized for this purpose and without the port obviously obstructing the patient in daily life.
During infusion, the active substance is removed from the
reservoir102 of the
port body101 via a
line104 connected to a
connection tube103 of the port and is delivered to the patient (for example, a vein or artery of the patient). The catheter is here implanted together with the port into the patient and laid such that the active substance is transported to a predetermined location in the patient. However, as shown in FIG. 1, the
opening107 through the
port body101 communicating with the
conduit104 is typically at a higher elevation than the bottom of the
reservoir102 so that when administering an infusion, the
active substance level108 needs to be higher than the
opening107 in order for the active substance to flow through the
opening107 and into the
conduit104. When one infusion is completed, there is a big problem that active substances remain in the
reservoir102 at a space lower than the
opening107, and the substances may contaminate the active substances in the next infusion after being left in the
reservoir102 for a long time. This is not allowed. More likely, the port also exists as a blood sampling device, i.e., blood is returned from the
catheter104 to the
reservoir102 and drawn out of the body by the
atraumatic needle106 with a negative pressure effect. After the blood drawing is completed, the blood may remain in the
reservoir chamber102 at a position lower than the
opening107, which is not allowed.
More specifically, the right-angle puncture of the atraumatic needle is different from the puncture mode of a common infusion needle, so that firstly, the manufacturing process is complex, and secondly, the operation of a medical care user is inconvenient. In addition, during practical use, the effective length of the needle tube needs to be selected by comprehensively considering the depth of the injection port body implanted into subcutaneous tissue, the thickness of an injection piece, the height of a liquid storage cavity of the injection port and other factors, is too short (a needle point hole does not completely support the liquid storage cavity and can cause liquid medicine to leak) and too long (the needle point penetrates the bottom surface of the liquid storage cavity to damage the needle point and the skin of the puncture point cannot be completely attached and fixed with the needle base), and can cause adverse effects.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provides an infusion port and a using method thereof.
The purpose of the invention is realized by the following technical scheme:
an infusion port comprises
A port body;
a reservoir disposed within the port for containing a medically active substance;
a connecting tube for securing the catheter and the port body so as to establish fluid communication between the reservoir and the catheter;
the injection piece is fixedly arranged on the harbor body and is used for the atraumatic needle to puncture and enter the liquid storage cavity;
the plane of the lowest edge of the liquid storage cavity is always higher than or equal to the lowest point of the guide pipe, and the liquid storage cavity and the guide pipe have a height difference h which is more than or equal to 0.
Preferably, the lowest edge of the reservoir chamber is the bottom inner wall of the harbor body, and the bottom inner wall is a plane.
Preferably, the harbor body further comprises a bottom outer wall having a cross-sectional profile conforming to the cross-sectional profile of the bottom inner wall.
Preferably, the reservoir chamber has a first port and a second port, the minimum aperture of the first port is larger than the maximum aperture of the second port, the syringe is fixed in the first port, and the conduit is communicated with the second port.
Preferably, the first port is arranged obliquely, the plane where the first port is located and the plane where the lowest edge is located form an included angle alpha, and alpha is larger than 0 degree and smaller than 90 degrees.
Preferably, the port body has an extension pipe, and the connection pipe is fitted around the extension pipe to fix the guide pipe thereto.
Preferably, the bottom inner wall of the extension tube is an extension of the bottom inner wall of the harbor body.
The invention also discloses a transfusion port, which comprises
A port body;
a reservoir disposed within the port for containing a medically active substance;
a connecting tube for securing the catheter and the port body so as to establish fluid communication between the reservoir and the catheter;
the injection piece is fixedly arranged on the harbor body and is used for the atraumatic needle to puncture and enter the liquid storage cavity;
the liquid storage cavity comprises a bottom inner wall, the flowing connection between the bottom inner wall and the guide pipe has a height difference h, and h is more than or equal to 0.
Preferably, the bottom inner wall has at least one flat surface.
Preferably, the cross section of the liquid storage cavity is a semi-hollow circle, a 3/4 hollow circle, a hollow circle or a hollow ellipse.
Preferably, the reservoir chamber has a first port and a second port, the minimum aperture of the first port is larger than the maximum aperture of the second port, the syringe is fixed in the first port, and the conduit is communicated with the second port.
Preferably, the first port is arranged obliquely, the plane where the first port is located and the plane where the lowest edge is located form an included angle alpha, and alpha is larger than 0 degree and smaller than 90 degrees.
Preferably, the port body has an extension pipe, and the connection pipe is fitted around the extension pipe to fix the guide pipe thereto.
The invention also discloses a transfusion port, which comprises
A port body;
a reservoir disposed within the port for containing a medically active substance;
a connecting tube for securing the catheter and the port body so as to establish fluid communication between the reservoir and the catheter;
the injection piece is fixedly arranged on the harbor body and is used for the atraumatic needle to puncture and enter the liquid storage cavity;
the harbor body comprises a bottom inner wall, and a height difference h is formed between the bottom inner wall and the lowest point of the conduit, wherein h is more than or equal to 0.
Preferably, the harbor body further comprises a bottom outer wall having a cross-sectional profile conforming to the cross-sectional profile of the bottom inner wall.
Preferably, the bottom inner wall is at least partially planar.
Preferably, the reservoir chamber has a first port and a second port, the minimum aperture of the first port is larger than the maximum aperture of the second port, the syringe is fixed in the first port, and the conduit is communicated with the second port.
Preferably, the first port is arranged obliquely, the plane where the first port is located and the plane where the lowest edge is located form an included angle alpha, and alpha is larger than 0 degree and smaller than 90 degrees.
The invention also discloses a using method of the transfusion port, which comprises the steps of,
configuring a port, the port comprising
A port body;
a reservoir disposed within the port for containing a medically active substance;
a connecting tube for securing the catheter and the port body so as to establish fluid communication between the reservoir and the catheter;
the injection piece is fixedly arranged on the harbor body and is used for the atraumatic needle to puncture and enter the liquid storage cavity;
the plane of the lowest edge of the liquid storage cavity is always higher than or equal to the lowest point of the guide pipe, the liquid storage cavity and the guide pipe have a height difference h, and h is more than or equal to 0;
a non-invasive needle is configured, and the needle body of the non-invasive needle is linear;
and (3) penetrating the needle body of the atraumatic needle through the injection piece and inserting the atraumatic needle into the liquid storage cavity of the transfusion port.
The invention has the following beneficial effects: because the height difference exists between the bottom inner wall of the port body and the lowest point of the conduit, the direct flow is ensured in the infusion process, and the medical active substance can not remain in the liquid storage cavity; and the liquid storage cavity and the silica gel are obliquely arranged and matched with the linear type non-traumatic needle, so that the operation and the use of medical personnel are facilitated.
Drawings
The technical scheme of the invention is further explained by combining the accompanying drawings as follows:
FIG. 1: is a structural schematic diagram of a transfusion port and a non-invasive needle matched with the transfusion port in the prior art;
FIG. 2: is a schematic structural view of a preferred embodiment of the port of the invention;
fig. 3 a-3 d: is a cross-sectional view taken along a-a in fig. 2, showing four structures, respectively;
FIG. 4: the invention is a schematic use diagram of the transfusion port.
Detailed Description
The present invention will be described in detail below with reference to specific embodiments shown in the drawings. These embodiments are not intended to limit the present invention, and structural, methodical, or functional changes that may be made by one of ordinary skill in the art in light of these embodiments are intended to be within the scope of the present invention.
In the description of the present invention, it is to be understood that the terms "center", "longitudinal", "lateral", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", and the like, indicate orientations or positional relationships based on those shown in the drawings, and are used only for convenience in describing the present invention and for simplicity in description, and do not indicate or imply that the referenced devices or elements must have a particular orientation, be constructed and operated in a particular orientation, and thus, are not to be construed as limiting the present invention. Furthermore, the terms "first", "second", etc. are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first," "second," etc. may explicitly or implicitly include one or more of that feature. In the description of the present invention, "a plurality" means two or more unless otherwise specified.
In the description of the present invention, it should be noted that, unless otherwise explicitly specified or limited, the terms "mounted," "connected," and "connected" are to be construed broadly, e.g., as meaning either a fixed connection, a removable connection, or an integral connection; can be mechanically or electrically connected; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meaning of the above terms in the present invention can be understood by those of ordinary skill in the art through specific situations.
The present invention will be described in detail below with reference to the embodiments with reference to the attached drawings.
As shown in fig. 2 to 4, the present invention discloses an infusion port, which comprises, similar to the prior art:
a port body 1;
a
reservoir2 disposed within the port body 1 for containing a medically active substance; liquid storage herein means that there is partial storage of the medical active substance in the cavity during infusion;
a connecting
tube3 for fixing the catheter 4 and the port body 1 so as to establish a fluid connection between the
reservoir2 and the catheter 4;
and the
injection piece5 is fixedly arranged on the port body 1 and is used for puncturing the
atraumatic needle6 and entering the
liquid storage cavity2. The injection member is typically a self-sealing membrane through which the
atraumatic needle6 passes to communicate with the connector. The membrane is generally made of silica gel.
It should be understood by those skilled in the art that although the technical names of the present invention are the same as those of the prior art, the structure thereof is different from that of the prior art, and the following detailed description is made.
Referring specifically to fig. 2, the harbor body 1 comprises a bottom
outer wall10, the lowest edge of the
reservoir chamber2 is the bottom
inner wall7 of the harbor body 1, and the cross-sectional profile of the bottom
outer wall10 is identical to the cross-sectional profile of the bottom
inner wall7.
The
liquid storage cavity2 is provided with a
first port8 and a second port 9, the minimum caliber of the
first port8 is larger than the maximum caliber of the second port 9, and smooth transition is formed from the
first port8 to the second port 9, namely the liquid storage cavity is in an irregular bell-mouth shape. The
injection member5 is fixed in the
first port8, and the conduit 4 is communicated with the second port 9.
As shown in fig. 2, the
first port8 is disposed obliquely so that the axial section of the
reservoir2 is triangular. The plane of the
first port8 and the plane of the lowest edge of the
liquid storage cavity2 form an included angle alpha, and alpha is more than 0 degree and less than 90 degrees.
In the preferred embodiment, the
first port8 and the
injection member5 are parallel to each other, i.e. the inclination angle of the
injection member5 is the same as the inclination angle of the
first port8, and of course, the skilled technician will be able to consider various considerations and the inclination angle of the
injection member5 and the inclination angle of the
first port8 may be different. Most importantly, the lowest point of the
first port8 and the
syringe5 is almost the same height as the lowest edge of the
reservoir2, ensuring that the port body of the implanted port can be kept at the lowest height.
The definition of the cross-section of the
reservoir2 according to the invention can be seen in connection with fig. 3a to 3 d.
In particular, the skilled person will be able to set the cross-section of the
reservoir2 to be semi-hollow circular, 3/4 hollow circular, hollow oval or other, based on various considerations. One skilled in the art should be aware of: in order to prevent the port body from rotating or unnecessarily shaking after the subcutaneous tissue is implanted into the transfusion port, two sides of the port body 1 can be provided with flat side wings or an encapsulated block structure (not shown in the figure), and the side wings can also be provided with suture holes so that medical staff can fix the transfusion port during operation.
As shown in fig. 3a and 3b, the cross section of the
reservoir2 is a semi-hollow circle, 3/4 hollow circle, the bottom
inner wall7 has at least one
plane12, and the
plane12 is the plane of the lowest edge of the
reservoir2; if the cross section of the
reservoir2 disclosed in fig. 3c and 3d is a hollow circle or a hollow ellipse, the plane of the lowest point is the plane of the lowest edge of the
reservoir2.
As can be seen from the figure 2, the plane of the lowest edge of the
liquid storage cavity2 is always higher than or equal to the lowest point of the conduit 4, and the two have a height difference h which is more than or equal to 0, namely, during transfusion, the medical active substance can directly flow into the conduit 4 from the
liquid storage cavity2, and no residue is generated in the
liquid storage cavity2.
It should be noted that the lowest edge is not compared with the ground, but is the lowest edge located at the deepest part of the patient after being implanted into the subcutaneous tissue of the patient.
The harbor body 1 has an
extension pipe11, and the
connection pipe3 is fitted around the outer periphery of the
extension pipe11 to fix the guide pipe 4 thereto. The bottom inner wall of the
extension tube11 is an extension of the bottom
inner wall7 of the harbor body 1. The
extension tube11 is only used for connecting the catheter 4 and the harbor body 1, so the length and the thickness of the
extension tube11 are not considered in the invention, and the specific connection mode can be a connection mode commonly used by technicians in the field such as spinning and buckling, and the like, and the detailed description is not repeated in the invention.
In the preferred embodiment of the invention it is disclosed that the flow connection between the bottom
inner wall7 and the conduit 4 has a height difference h, h ≧ 0. The skilled person will be able to base various considerations on the fact that, in addition to the fact that the bottom edge of the axial cross section of the bottom
inner wall7 is substantially parallel to the bottom edge of the axial cross section of the catheter 4 as disclosed in fig. 2, the bottom edge of the axial cross section of the bottom
inner wall7 may also be at an angle with the bottom edge of the axial cross section of the catheter 4, that is, the bottom edge of the axial cross section of the bottom
inner wall7 is inclined from the
first port8 to the second port 9, so as to generate the effect of gradual closing up, and further facilitate the transmission of the medical active.
In the preferred embodiment of the invention, the height difference h between the bottom
inner wall7 and the lowest point of the conduit 4 is also disclosed, and h is more than or equal to 0. The skilled person will be able to base various considerations on the fact that, in addition to the fact that the
bottom wall7 is shown in fig. 2 as a smooth surface, it is also possible to provide a special surface with flow channels, for example a groove, with a height difference h between the lowest point of the groove and the lowest point of the conduit 4, h ≧ 0.
The invention also discloses a using method of the implantable transfusion port, which comprises the following steps:
providing an infusion port having the structure set forth above;
a
non-injury needle6 is configured, and the needle body of the
non-injury needle6 is linear;
as shown in FIG. 4, the port is placed under the
subcutaneous tissue13 with some or all of the
injection member5 in contact with the subcutaneous tissue. The body of the
atraumatic needle6 is inserted into the
reservoir2 of the port through the oblique subcutaneous tissue and the
oblique injection piece5.
The
first port8 and the
injection member5 are arranged obliquely, which greatly reduces the overall height of the port at the site of implantation, reduces the pulling force of the port on the skin of the patient and reduces the pain and foreign body sensation of the patient.
The invention is matched with a linear type non-invasive needle, is beneficial to the operation and use of medical personnel, improves the effective area utilization rate of a puncture window, reduces the complexity of the operation and reduces the incidence rate of postoperative mechanical phlebitis; reduces the incidence of ischemic necrosis caused by skin tension loss after operation.
It should be understood that although the present description refers to embodiments, not every embodiment contains only a single technical solution, and such description is for clarity only, and those skilled in the art should make the description as a whole, and the technical solutions in the embodiments can also be combined appropriately to form other embodiments understood by those skilled in the art.
The above-listed detailed description is only a specific description of a possible embodiment of the present invention, and they are not intended to limit the scope of the present invention, and equivalent embodiments or modifications made without departing from the technical spirit of the present invention should be included in the scope of the present invention.
Claims (19)
1. An infusion port comprises
A port body (1);
a reservoir (2) arranged in the port body (1) for containing a medically active substance;
-a connecting tube (3) for fixing the catheter (4) and the port body (1) so as to establish a fluid connection between the reservoir (2) and the catheter (4);
the injection piece (5) is fixedly arranged on the harbor body (1) and is used for puncturing the atraumatic needle (6) and entering the liquid storage cavity (2);
the method is characterized in that:
the plane of the lowest edge of the liquid storage cavity (2) is always higher than or equal to the lowest point of the guide pipe (4), and the liquid storage cavity and the guide pipe have a height difference h which is more than or equal to 0.
2. The port of claim 1, wherein: the lowest edge of the liquid storage cavity (2) is a bottom inner wall (7) of the harbor body (1), and the bottom inner wall (7) is a plane.
3. The port of claim 2, wherein: the harbor body (1) further comprises a bottom outer wall (10) having a cross-sectional profile corresponding to the cross-sectional profile of the bottom inner wall (7).
4. The port of claim 1, wherein: the liquid storage cavity (2) is provided with a first port (8) and a second port (9), the minimum caliber of the first port (8) is larger than the maximum caliber of the second port (9), the injection piece (5) is fixed in the first port (8), and the conduit (4) is communicated with the second port (9).
5. The port of claim 4, wherein: the first port (8) is arranged in an inclined way, the plane of the first port and the plane of the lowest edge are arranged in an included angle (alpha),
0°<α<90°。
6. the port of any one of claims 1 to 5, wherein: the harbor body (1) is provided with an extension pipe (11), and the connecting pipe (3) is sleeved on the periphery of the extension pipe (11) to fix the guide pipe (4) with the extension pipe.
7. The port of claim 6, wherein: the bottom inner wall of the extension pipe (11) is the extension of the bottom inner wall (7) of the harbor body (1).
8. An infusion port comprises
A port body (1);
a reservoir (2) arranged in the port body (1) for containing a medically active substance;
-a connecting tube (3) for fixing the catheter (4) and the port body (1) so as to establish a fluid connection between the reservoir (2) and the catheter (4);
the injection piece (5) is fixedly arranged on the harbor body (1) and is used for puncturing the atraumatic needle (6) and entering the liquid storage cavity (2);
the method is characterized in that: the liquid storage cavity (2) comprises a bottom inner wall (7), the flowing connection between the bottom inner wall (7) and the guide pipe (4) has a height difference h, and h is more than or equal to 0.
9. The port of claim 8, wherein: the bottom inner wall (7) has at least one plane (12).
10. The port of claim 8, wherein: the cross section of the liquid storage cavity (2) is a semi-hollow circle, 3/4 hollow circle, hollow circle or hollow ellipse.
11. The port of claim 8 or 9 or 10, wherein: the liquid storage cavity (2) is provided with a first port (8) and a second port (9), the minimum caliber of the first port (8) is larger than the maximum caliber of the second port (9), the injection piece (5) is fixed in the first port (8), and the conduit (4) is communicated with the second port (9).
12. The port of claim 11, wherein: the first port (8) is arranged in an inclined way, the plane of the first port and the plane of the lowest edge are arranged in an included angle (alpha),
0°<α<90°。
13. the port of claim 8 or 9 or 10, wherein: the harbor body (1) is provided with an extension pipe (11), and the connecting pipe (3) is sleeved on the periphery of the extension pipe (11) to fix the guide pipe (4) with the extension pipe.
14. An infusion port comprises
A port body (1);
a reservoir (2) arranged in the port body (1) for containing a medically active substance;
-a connecting tube (3) for fixing the catheter (4) and the port body (1) so as to establish a fluid connection between the reservoir (2) and the catheter (4);
the injection piece (5) is fixedly arranged on the harbor body (1) and is used for puncturing the atraumatic needle (6) and entering the liquid storage cavity (2);
the method is characterized in that: the harbor body (1) comprises a bottom inner wall (7), wherein a height difference h is formed between the bottom inner wall (7) and the lowest point of the guide pipe (4), and h is more than or equal to 0.
15. The port of claim 14, wherein: the harbor body (1) further comprises a bottom outer wall (10) having a cross-sectional profile corresponding to the cross-sectional profile of the bottom inner wall (7).
16. The port of claim 14, wherein: the bottom inner wall (7) is at least partially planar.
17. The port of claim 14, wherein: the liquid storage cavity (2) is provided with a first port (8) and a second port (9), the minimum caliber of the first port (8) is larger than the maximum caliber of the second port (9), the injection piece (5) is fixed in the first port (8), and the conduit (4) is communicated with the second port (9).
18. The port of claim 17, wherein: the first port (8) is arranged in an inclined way, the plane of the first port and the plane of the lowest edge are arranged in an included angle (alpha),
0°<α<90°。
19. the use method of the transfusion port is characterized in that: comprises the steps of (a) carrying out,
configuring a port, the port comprising
A port body (1);
a reservoir (2) arranged in the port body (1) for containing a medically active substance;
-a connecting tube (3) for fixing the catheter (4) and the port body (1) so as to establish a fluid connection between the reservoir (2) and the catheter (4);
the injection piece (5) is fixedly arranged on the harbor body (1) and is used for puncturing the atraumatic needle (6) and entering the liquid storage cavity (2);
the plane of the lowest edge of the liquid storage cavity (2) is always higher than or equal to the lowest point of the guide pipe (4), and the liquid storage cavity and the guide pipe have a height difference h which is more than or equal to 0;
a non-injury needle (6) is configured, and the needle body of the non-injury needle (6) is linear;
and (3) penetrating the needle body of the atraumatic needle (6) through the injection piece (5) and inserting the atraumatic needle into the liquid storage cavity (2) of the transfusion port.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010466767.9A CN111588941A (en) | 2020-05-28 | 2020-05-28 | Infusion port and method of use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010466767.9A CN111588941A (en) | 2020-05-28 | 2020-05-28 | Infusion port and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111588941A true CN111588941A (en) | 2020-08-28 |
Family
ID=72181750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010466767.9A Pending CN111588941A (en) | 2020-05-28 | 2020-05-28 | Infusion port and method of use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111588941A (en) |
Citations (5)
* Cited by examiner, † Cited by third partyPublication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4710167A (en) * | 1985-05-21 | 1987-12-01 | Applied Precision Limited | Implantable device for chronically injecting a substance, in particular a therapeutant |
EP0309092A1 (en) * | 1987-08-25 | 1989-03-29 | Infusaid, Inc. | Implantable device |
US5263930A (en) * | 1990-03-01 | 1993-11-23 | William D. Ensminger | Implantable access devices |
US20100063461A1 (en) * | 2006-08-03 | 2010-03-11 | Esteve Marc Jose | Compact linear implantable site |
CN106029124A (en) * | 2013-12-19 | 2016-10-12 | 美敦力迷你迈德公司 | On-body injector and method of use |
-
2020
- 2020-05-28 CN CN202010466767.9A patent/CN111588941A/en active Pending
Patent Citations (5)
* Cited by examiner, † Cited by third partyPublication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4710167A (en) * | 1985-05-21 | 1987-12-01 | Applied Precision Limited | Implantable device for chronically injecting a substance, in particular a therapeutant |
EP0309092A1 (en) * | 1987-08-25 | 1989-03-29 | Infusaid, Inc. | Implantable device |
US5263930A (en) * | 1990-03-01 | 1993-11-23 | William D. Ensminger | Implantable access devices |
US20100063461A1 (en) * | 2006-08-03 | 2010-03-11 | Esteve Marc Jose | Compact linear implantable site |
CN106029124A (en) * | 2013-12-19 | 2016-10-12 | 美敦力迷你迈德公司 | On-body injector and method of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5620419A (en) | 1997-04-15 | Port stabilizer ring |
CA1306916C (en) | 1992-09-01 | Dual access infusion and monitoring system |
US5997524A (en) | 1999-12-07 | Catheter assembly for percutaneous access to subcutaneous port |
EP2320979B1 (en) | 2020-12-02 | Conical diffuser tip |
CN111588940A (en) | 2020-08-28 | Implanted infusion port and using method |
CN212651171U (en) | 2021-03-05 | Implanted transfusion port |
US20170128709A1 (en) | 2017-05-11 | Venous Access Implantable Port |
CN212651172U (en) | 2021-03-05 | Transfusion port |
WO1996029112A1 (en) | 1996-09-26 | Vascular access system |
CN112791267B (en) | 2024-12-17 | An infusion port |
CN111588941A (en) | 2020-08-28 | Infusion port and method of use |
CN215460909U (en) | 2022-01-11 | Implantable drug delivery device |
CN108785791B (en) | 2020-12-18 | Double-lumen venous transfusion port capable of preventing thrombosis and preventing secondary infection |
WO2023181979A1 (en) | 2023-09-28 | Therapeutic device for brain diseases, connector for therapeutic devices, and connector fixing tool for therapeutic devices |
CN113599620A (en) | 2021-11-05 | Implantable drug delivery device |
CN217286741U (en) | 2022-08-26 | Medical implantable drug delivery device |
CN203154560U (en) | 2013-08-28 | Biatrial catheter |
CN216366290U (en) | 2022-04-26 | Implantable drug delivery device |
CN216366291U (en) | 2022-04-26 | Vortex type implanted drug delivery device and infusion device |
CN218458411U (en) | 2023-02-10 | Implantable drug delivery device |
CN221600887U (en) | 2024-08-27 | Oncology device of dosing |
CN222510590U (en) | 2025-02-21 | Circulating transfusion port |
CN217793261U (en) | 2022-11-15 | Continuous drug administration device in superficial solid tumor |
JPS63296770A (en) | 1988-12-02 | Subcutaneous embedding type reservoir |
CN216366156U (en) | 2022-04-26 | Transfusion needle connecting mechanism and butterfly wing needle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
2020-08-28 | PB01 | Publication | |
2020-08-28 | PB01 | Publication | |
2020-09-22 | SE01 | Entry into force of request for substantive examination | |
2020-09-22 | SE01 | Entry into force of request for substantive examination | |
2024-09-10 | RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200828 |
2024-09-10 | RJ01 | Rejection of invention patent application after publication |